What is the brand name for suvorexant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Suvorexant Brand Name

Suvorexant is marketed under the brand name Belsomra® 1.

This orexin receptor antagonist was approved by the FDA in 2014 for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance 1, 2. The medication is available in multiple tablet strengths (5 mg, 10 mg, 15 mg, and 20 mg) 1.

Belsomra represents the first dual orexin receptor antagonist (DORA) approved in the United States and Japan, offering a novel mechanism of action distinct from traditional sleep medications like benzodiazepines and Z-drugs 3, 2, 4.

References

Related Questions

What is the generic name of Belsomra?
What is the mechanism of action of suvorexant?
Is Dayvigo (suvorexant) safe for an 82‑year‑old patient?
In an adult with severe insomnia for two weeks despite multiple oral agents and a nightly dose of suvorexant 10 mg, can emergency department staff safely induce sleep using intravenous medications?
Can Belsomra (suvorexant) cause elevated liver enzymes?
Can letrozole be safely co‑administered with rivaroxaban in an adult post‑menopausal woman receiving letrozole for hormone‑receptor‑positive breast cancer who requires anticoagulation (e.g., for atrial fibrillation or venous thromboembolism)?
What is the recommended evaluation and management approach for hematologic disorders such as anemia and thrombocytopenia?
What medication treatment is recommended for insomnia with early morning awakening?
What is the appropriate initial dosing of suvorexant (Belsomra) for insomnia?
Does a female patient who has been taking bupropion extended-release (150 mg daily) for five years need to taper the medication when discontinuing it?
What is the recommended starting dose of Lunest (zaleplon) and how should it be adjusted for elderly patients or those with hepatic impairment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.